Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A Phase II trial of suramin monthly x 3 for hormone-refractory prostate carcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A Phase II trial of suramin monthly x 3 for hormone-refractory prostate carcinoma.
A Phase II trial of suramin monthly x 3 for hormone-refractory prostate carcinoma. Cancer. 2004 Jan 01; 100(1):65-71.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Carcinoma
Dexamethasone
Drug Administration Schedule
Drug Resistance, Neoplasm
Humans
Injections, Intravenous
Male
Middle Aged
Prostate-Specific Antigen
Prostatic Neoplasms
Suramin
Survival Analysis
Treatment Outcome
authors with profiles
Mark J. Ratain
Walter M. Stadler
Theodore Karrison
Everett E. Vokes